Sign in
Taking people in United StatesNo phase

Fat metabolism in people with and without obstructive sleep apnea

Studies how the body handles fat in people with obstructive sleep apnea.

Key facts

Who runs it
University of Miami
Where
Miami, United StatesSee the site
Trial code
Registry title
Metabolism and Sleep Apnea Treatment
Status
Recruiting
People taking part
100 people, planned
Started
20 May 2022
Expected to end
1 Sept 2027
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • PAP Therapy
  • Lifestyle Counseling Intervention
Record updated
23 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with and without obstructive sleep apnea (breathing stops during sleep). It studies how the body handles fat. People with moderate-to-severe sleep apnea may go on to a second part with PAP therapy and lifestyle counseling.

Age
18 to 70 years
Sex
All sexes
Disease stage
First part: people with or without sleep apnea. Second part: moderate-to-severe sleep apnea (AHI ≥ 15/h).
Earlier treatment
No current or prior use of PAP or oral appliance therapy for sleep apnea. For the second part, PAP use of > 4 h/night on 70% of nights during a 1-week trial period, and all first-part tests completed.

Main reasons for not taking part

  • BMI > 40 kg/m2 (second part: ≥ 40 kg/m2)
  • Type 1 or Type 2 diabetes
  • Past heart attack, heart artery procedure, heart failure or stroke
  • Other sleep disorders, central sleep apnea, or oxygen use
  • Resting awake oxygen level (SpO2) < 90%

The registry criteria, word for word

Show all 30 criteriaShow less

Who can take part

  • Age between 18-70 years
  • Ability to provide consent
  • Age between 18-70 years
  • Ability to provide consent
  • Moderate-to-severe OSA (AHI ≥ 15/h)
  • Demonstration of Positive Airway Pressure (PAP) use of > 4 h/night on 70% of the nights during 1-week run-in period
  • Successful completion of all of the procedures for Aim 1

Who cannot take part

  • Current or prior use of PAP or oral appliance therapy for OSA
  • Use of oral corticosteroids
  • Current use of PAP or oral appliance therapy for OSA
  • Commercial driver or report of motor vehicle accident or near-miss due to sleepiness within the 2 previous years
  • Use of oral corticosteroids
  • Prevalent myocardial infarction, coronary revascularization, heart failure, and stroke
  • Type 1 or Type 2 diabetes mellitus
  • Unstable medical conditions that may preclude enrollment in the protocol such as: uncontrolled angina and/or congestive heart failure, uncontrolled blood pressure or resistant hypertension, severe chronic obstructive pulmonary disease, cancer, and active psychiatric disease (e.g., major depression)
  • Other sleep disorders (e.g., circadian rhythm disorder, self-reported habitual sleep duration < 6h)
  • Central sleep apnea, obesity hypoventilation syndrome or Cheyne-Stokes respiration based on the home sleep test
  • Type 1 or Type 2 diabetes mellitus
  • Unstable medical conditions that may preclude enrollment in the protocol such as: uncontrolled angina and/or congestive heart failure, uncontrolled blood pressure or resistant hypertension, severe chronic obstructive pulmonary disease, cancer, and active psychiatric disease (e.g., major depression)
  • Other sleep disorders (e.g., circadian rhythm disorder, self-reported habitual sleep duration < 6h)
  • Central sleep apnea, obesity hypoventilation syndrome or Cheyne-Stokes respiration based on the home sleep test
  • Body Mass Index (BMI) > 40 kg/m2
  • Use of supplemental oxygen during wakefulness or sleep
  • Resting awake Oxygen Saturation (SpO2) < 90%; Aim 2 Group:
  • BMI: ≥ 40 kg/m2
  • Epworth sleepiness score of 18 or more
  • Participation in another clinical trial
  • Use of supplemental oxygen during wakefulness or sleep
  • Resting awake SpO2 < 90%

Other criteria

  • Aim 1 Group:

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • University of MiamiMiami, United StatesContact: Naresh Punjabi, MDTaking people

About the trial

What the trial wants to find out

The purpose of this research study is to see if obstructive sleep apnea (OSA) is associated with abnormalities in fat metabolism. Through this research study, the Investigator will evaluate how fat is metabolized in people with and without sleep apnea, what substances the fat tissue releases, and how these substances might change the way the body uses energy and sugar.

The 3 groups in the trial

  • No Intervention (Aim 1) GroupNo study treatment, for comparison

    Participants in this group will not receive an intervention and will only undergo several testing procedures conducted within 3 to 4 weeks to assess OSA severity.

  • PAP Therapy and Lifestyle Intervention (Aim 2) GroupTreatment being tested

    Participants in the Aim 1 Group found to have moderate to severe OSA (defined as having a Apnea-Hypopnea Index (AHI) of 15.0 events/hour or more) randomized to this arm will receive the PAP therapy and Lifestyle Intervention for 12 weeks.

    Treatment: PAP Therapy and Lifestyle Counseling Intervention

  • Lifestyle Intervention Only (Aim 2) GroupTreatment being tested

    Participants in the Aim 1 Group found to have moderate to severe OSA (defined as having a Apnea-Hypopnea Index (AHI) of 15.0 events/hour or more) randomized to this arm will receive only the Lifestyle Intervention for 12 weeks.

    Treatment: Lifestyle Counseling Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Metabolism and Sleep Apnea Treatment
Plain-language title
Fat metabolism in people with and without obstructive sleep apneaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05539716, who can take part
Record updated
23 March 2026